Article

Testosterone Therapy and Cardiovascular Risk

Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA, along with his coauthors, explore and clarify in the February 2015 issue of Mayo Clinic Proceedings, the value of testosterone therapy in men, and in particular the issue of cardiovascular risk.  

Source: YouTube

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
DNA helix | Image Credit: © Radomir Jovanovic - stock.adobe.com
Medical stethoscope and dollar bills | Image Credit: © Kuzmick - stock.adobe.com
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.